Hannah Kleine-Weber
Molecules and Cells · 2020
A researcher in the Science corpus: 3 papers; trusts 0 researchers and is trusted by 3 researchers here, as inferred from the citation graph.
Who trusts Hannah Kleine-Weber overall
Papers from Hannah Kleine-Weber's perspective
Ordered by how strongly the researchers Hannah Kleine-Weber trusts endorse each paper. Same corpus, a different order for every researcher.
- A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury (Nature Medicine)
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis (Journal of Pathology)
- Isolation and Characterization of Viruses Related to the SARS Coronavirus from Animals in Southern China (Science)
- Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats. (Proceedings of the National Academy of Sciences of the United States of America)
- Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry (Proceedings of the National Academy of Sciences of the United States of America)
- A Transmembrane Serine Protease Is Linked to the Severe Acute Respiratory Syndrome Coronavirus Receptor and Activates Virus Entry (Journal of Virology)
- Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR (Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin)
- Efficient Activation of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein by the Transmembrane Protease TMPRSS2 (Journal of Virology)
- Angiotensin-converting enzyme 2 protects from severe acute lung failure (Nature)
Their papers
- A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells (2020) — 1,708 citations
- The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells (2020) — 742 citations
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor (2020) — 18,267 citations